Skip to main content
. 2007 Apr;9(2):184–196. doi: 10.2353/jmoldx.2007.060091

Table 1.

RET Proto-Oncogene Sequence Variation

RET exon Codon Codon sequence change* Amino acid change References
10 603 AAA → CAA K603Q 20
609 TGC → AGC C609S 3
TGC → CGC C609R 3, 20, 24
TGC → GGC C609G 3, 20
• TGC → TAC C609Y 3, 20, 24
• TGC → TCC C609S 3, 20
TGC → TTC C609F 3
TGC → TGG C609W 3, 20, 38
611 TGC → AGC C611S 3, 20
• TGC → CGC C611R 3, 20
TGC → GGC C611G 3, 20, 24
• TGC → TAC C611Y 3, 20, 24
TGC → TCC C611S 3
• TGC → TTC C611F 3, 20
TGC → TGG C611W 3, 20, 24
618 TGC → AGC C618S 3, 20, 24
• TGC → CGC C618R 3, 20, 24
• TGC → GGC C618G 3, 20, 24
• TGC → TAC C618Y 3, 20, 24
• TGC → TCC C618S 3, 20, 24
• TGC → TTC C618F 3, 20, 24
TGC → TGG C618W 3
620 • TGC → AGC C620S 3, 20
TGC → CGC C620R 3, 20, 24
TGC → GGC C620G 3, 20, 24
• TGC → TAC C620Y 3, 20, 24
• TGC → TCC C620S 3, 20, 24
• TGC → TTC C620F 3, 20, 24
• TGC → TGG C620W 3, 20
11 630 TGC → CGC C630R 3
TGC → TAC C630Y 3, 20
TGC → TTC C630F 3, 20, 24
TGC → TCC C630S 3, 20
631 • GAC → GAT D631D 3
GAC → TAC D631Y 3
GAC → GAA D631E 3, 34
GAC → GTC D631V 3, 34
634 • TGC → AGC C634S 3, 20, 24
• TGC → CGC C634R 3, 20, 24
• TGC → GGC C634G 3, 20, 24
• TGC → TAC C634Y 3, 20, 24
• TGC → TCC C634S 3, 20, 24
• TGC → TTC C634F 3, 20, 24
• TGC → TGG C634W 3, 20, 24
640 GCC → GGC A640G 20
13 768 • GAG → GAC E768D 3, 20, 24
GAG → GAT E768D 3, 20
769 • CTT → CTG L769L 2, 19, 20
778 GTC → ATC V778I 20
781 CAG → CGG Q781R 20
790 TTG → TTT L790F 20, 24, 28
TTG → TTC L790F 20, 24, 28
791 TAT → TTT Y791F 24, 27, 28
14 804 • GTG → ATG V804M 3, 20, 24
• GTG → TTG V804L 3, 20, 24
GTG → CTG V804L 3
806 TAC → TGC§ Y806C 24, 35
844 CGG → CTG R844L 20, 24
852 ATC → ATG I852M 20, 29
16 912 CGG → CCG R912P 30
918 • ATG → ACG M918T 3, 20, 24
922 TCC → TAC S922Y 20, 31
*

Sequence variation is heterozygous unless otherwise stated in the text. Codon DNA sequence is listed with the nucleotide of change in bold for mutations and underlined for polymorphisms/sequence variants. •, available RET sequence variation samples. 

Rare sequence variants of unknown significance or not causative of MEN2 syndromes; see references. Three variants in codons 609 or 611 are within RET pathogenic codons yet are not associated with MEN2 syndromes. Variants at codons 922 and 852 were previously found in MTC patients, yet may not be causative of MEN2 syndromes. 

Benign polymorphism, 0.26 allelic frequency. 

§

806 is only pathogenic with 804 mutation on same allele.